Health Canada Advisory Panel Recommends Increased Accutane Physician Education
This article was originally published in The Pink Sheet Daily
Committee unanimously rejects patient registry system that would be similar to U.S. iPLEDGE risk management program.
You may also be interested in...
Wholesalers, pharmacists, prescribers and patients will have added responsibility under the iPLEDGE program.
Revised labeling for isotretinoin (Roche's Accutane and generics) suggests prescribers ask patients about psychiatric disorders prior to treatment initiation and continue that discourse throughout treatment
Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.